Polyrizon pays $3M for license to SciSparc's preclinical cannabinoid pain therapy 19.08.2024 12:28 Fiercebiotech.com Polyrizon pays $3M for license to SciSparc's preclinical cannabinoid pain therapy jwaldron Mon, 08/19/2024 - 05:28
